胸腺肿瘤,thymus neoplasms
1)thymus neoplasms胸腺肿瘤
英文短句/例句
1.Thymic tumours and dermoid cysts, although in the anterior mediastinum, may be closely related to the pulmonary trunk.胸腺肿瘤和皮样囊肿,虽然位于前纵隔,也可与肺动脉段密切相连。
2.Thymus Gland Transplantation Nursing Care胎儿胸腺移植治疗恶性肿瘤的护理
3.Studies on Anti-tumor and Anti-oxidative Effects of Thymopentin (TP5);胸腺五肽抗肿瘤和抗氧化作用的研究
4.Prognostic factors for thymic epithelial tumor:a retrospective study of 137 cases137例胸腺上皮肿瘤的预后影响因素
5.An Experimental Study on the Effect of Tumor Specific CTL Combined with Thymosin α1 against Tumor in Vivo肿瘤特异性CTL联合胸腺肽α1体内肿瘤杀伤效应的实验研究
6.Effects on Immune State of Thymosin α1 on 84 Cancer Patients with Chemotherapy;胸腺肽a1对84例肿瘤化疗患者免疫指标的影响
7.To Explore the Diagnosis Value of Spiral CT to Thymic Epithelial Tumors螺旋CT对胸腺上皮肿瘤的诊断价值探讨
8.Application of Sternocleidomastoid Flap in Operation on Parotid Benign Tumor胸锁乳突肌瓣在腮腺良性肿瘤切除术中的应用
9.Influence of Chemotherapy Combined with Thymopetidum on Cellular Immunity of Patients with Gastrointestinal Malignant Tumor in the Later Stage胸腺肽联合化疗对胃肠肿瘤者细胞免疫的影响
10.THE EFFECT OF THYMOPENTIN ON IMMUNE FUNCTION IN CHILDREN AFTER CHEMOTHERAPY FOR MALIGNANT TUMOR胸腺五肽对肿瘤病儿化疗停药后免疫功能影响
11.Results Thymomas and teratomas tended to be located in the anterior mediastinum, whereas neurogenic tumours and EDST predisposed to the posterior mediastinum.结果畸胎瘤和胸腺瘤位于前纵隔, 神经源性肿瘤和内胚窦瘤发生于后纵隔。
12.Purpose: To investigate the type of surgery appropriate for substernal benign thyroid tumor.目的:探讨胸骨后良性甲状腺肿瘤的手术治疗方式。
13.Conclusions: Surgery via cervical collar incision for substernal benign thyroid tumors is safe.结论:由颈部入路行胸骨后良性甲状腺肿瘤手术是安全的。
14.Method To resect tumor and some gland through inferolateral fold and areola mammae incision and to implant prosthesis to the posterior pectoralis major space.方法乳房下皱襞、乳晕切口切除肿瘤及腺体,胸大肌后间隙植入假体。
15.Treatment of advanced cancer with activat-ed fetal thymocyte and human nature IL-2--An analysis of 63 cases天然人白细胞介素-2及活化胎儿胸腺细胞治疗晚期恶性肿瘤63例
16.Study on Immunity Pharmacodynamics and Anti-tumor Pharmacodynamics of Thymosin Alpha-1 by Injection;注射用重组人胸腺肽a1免疫药效学及抗肿瘤药效学的初步研究
17.Activision of MMP-2 and Expression of MT1-MMP mRNA Correlated with Invasiveness in Thymic Epithelial Tumors;MMP-2活性与MT1-MMPmRNA表达在胸腺上皮肿瘤中的相关性
18.Significance of Pre-Operative and Post-Operative Immunoglobulin Assay in Patients with Malignant Tumor Undergone Thymus Transplantation;恶性肿瘤患者胸腺移植前后免疫球蛋白测定及临床意义
相关短句/例句
Thymic tumor胸腺肿瘤
3)thymus neoplasm要胸腺肿瘤
4)Thymus neoplasm/diagnosis胸腺肿瘤/诊断
5)Thymus neoplasms/surgery胸腺肿瘤/外科学
6)Thymus neoplasms/pathology胸腺肿瘤/病理学
延伸阅读
胸腺多肽,胸腺素F5,胸腺素,胸腺素注射液药物名称:胸腺肽注射液英文名:Thymopetidum Injection别名:胸腺多肽,胸腺素F5,胸腺素,胸腺素注射液、胸腺因子注射液、胸腺因子D注射液。性状:本品为无色或微黄色澄明液体。药理作用: 促使骨髓产生的干细胞转变为T细胞,从而增强细胞免疫功能。 从健康乳牛胸腺中提取制得的多肽类细胞免疫调节剂。可作用于T淋巴细胞分化的各个阶段,有调节和增强人体免疫功能的作用,可提高机体的防病抗病能力,缩短感染性疾病的治疗周期。用于原发或继发性免疫缺陷病或免疫功能失调引起的各种疾病、自身免疫性疾病以及病毒或细菌性感染和肿瘤的辅助治疗。适应症: 用于免疫缺陷病、恶性肿瘤及病毒性疾病。 用于治疗各种原发性或继发性T细胞缺陷病,某些自身免疫性疾病,各种细胞免疫功能低下的疾病及肿瘤的辅助治疗.用量用法: 肌注:每次2-10mg,每日或隔日1次。对于胸腺发育不全症患者应做替代治疗,每日1mg/kg,病情好转后改为维持量每周1mg/kg。 静脉滴注:一次20~80mg,溶于500ml,0.9%氯化钠注射液或5%葡萄糖注射液,一日1次或遵医嘱。注意事项:1.对于过敏体质者,注射前或治疗终止后再用药时需做皮内敏感试验(配成25μg/ml的溶液,皮内注射0.1ml),阳性反应者禁用。2.本品如出现混浊或絮状沉淀物等异常变化,禁忌使用。3. 有发热、头晕、皮疹等。规格: 注射剂:2mg/2ml;5mg/2ml。2ml:5mg;2ml:20mg类别:免疫调节剂